| Aug 7 |
AxoGen Q2 2024 Earnings Preview
|
| Aug 1 |
AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
| Jul 29 |
Stryker to Report Q2 Earnings: What's in the Cards?
|
| Jul 23 |
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
|
| Jul 12 |
AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock?
|
| Jul 1 |
Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
|
| Jun 25 |
AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection
|
| Jun 24 |
The past three years for AxoGen (NASDAQ:AXGN) investors has not been profitable
|
| Jun 24 |
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
|
| Jun 12 |
Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?
|
